UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature reviews. Clinical oncology, 2019-09, Vol.16 (9), p.563-580

2019

Link zum Volltext

Verfügbarkeit prüfen

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

The lancet oncology, 2019-01, Vol.20 (1), p.e54-e64

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6162

2024

Link zum Volltext

Verfügbarkeit prüfen

The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study

Arthritis research & therapy, 2019-03, Vol.21 (1), p.80-80, Article 80

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland

Allergology International, 2024-01, Vol.73 (1), p.143-150

2024

Link zum Volltext

Verfügbarkeit prüfen

Measurement of circulating CD21 - CD27 - B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers

Scientific reports, 2022-06, Vol.12 (1), p.9189-9189, Article 9189

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 pandemic on SLE: beyond the risk of infection

Lupus science & medicine, 2020-05, Vol.7 (1), p.e000408

2020

Link zum Volltext

Verfügbarkeit prüfen

ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis

Multiple sclerosis, 2020-10, Vol.26 (12), p.1599-1602

2020

Link zum Volltext

Verfügbarkeit prüfen

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines

Allergology International, 2023-04, Vol.72 (2), p.332-334

2023

Link zum Volltext

Verfügbarkeit prüfen

Worse cardiovascular and renal outcome in male SLE patients

Scientific reports, 2023-10, Vol.13 (1), p.18628-18628, Article 18628

2023

Link zum Volltext

Verfügbarkeit prüfen

Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE

Frontiers in immunology, 2021-03, Vol.12, p.645478-645478

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study

Lupus, 2021-09, Vol.30 (10), p.1565-1576

2021

Link zum Volltext

Verfügbarkeit prüfen

Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases

Swiss medical weekly, 2015, Vol.145, p.w14159

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

Swiss medical weekly, 2024-02, Vol.154, p.3630

2024

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site

Frontiers in immunology, 2019-11, Vol.10, p.2619-2619

2019

Link zum Volltext

Verfügbarkeit prüfen

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus

Frontiers in immunology, 2022-01, Vol.12, p.761395-761395

2022

Link zum Volltext

Verfügbarkeit prüfen

SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus

Frontiers in immunology, 2022-05, Vol.13, p.843059-843059

2022

Link zum Volltext

Verfügbarkeit prüfen

ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity

Genes, 2023-05, Vol.14 (5), p.1105

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)

BMC immunology, 2017-03, Vol.18 (1), p.17-17, Article 17

2017

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus

Frontiers in immunology, 2018-10, Vol.9, p.2090-2090

2018

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis - a multisystem disease

Swiss medical weekly, 2022-01, Vol.152, p.w30049

2022

Link zum Volltext

Verfügbarkeit prüfen

Management of giant-cell arteritis in Switzerland: an online national survey

Swiss medical weekly, 2023-04, Vol.153, p.40051

2023

Link zum Volltext

Verfügbarkeit prüfen

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine

Vaccines (Basel), 2023-08, Vol.11 (8), p.1335

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus

PloS one, 2018-01, Vol.13 (1), p.e0188695-e0188695

2018

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

TH open : companion journal to thrombosis and haemostasis, 2021-01, Vol.5 (1), p.e8-e13

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(76)
Science & Technology
(73)
Life Sciences & Biomedicine
(69)
Rheumatology
(35)
Female
(34)
Male
(29)
Middle Aged
(29)
Adult
(28)
Systemic Lupus Erythematosus
(20)
Patients
(19)
Immunology
(18)
Aged
(16)
Lupus
(14)
Autoimmune Diseases
(13)
Immunosuppressive Agents - Therapeutic Use
(11)
Life Sciences
(11)
Prospective Studies
(11)
Risk Factors
(11)
Arthritis
(9)
Sars-Cov-2
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis

The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study

Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland

Measurement of circulating CD21 - CD27 - B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers

Impact of COVID-19 pandemic on SLE: beyond the risk of infection

ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines

Worse cardiovascular and renal outcome in male SLE patients

Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE

Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study

Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus

SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus

ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity

Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus

Sarcoidosis - a multisystem disease

Management of giant-cell arteritis in Switzerland: an online national survey

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

Suchergebnisse filtern